AstraZeneca’s oncology portfolio gained momentum after a U.S. FDA advisory panel backed Truqap (capivasertib) combined with abiraterone and androgen deprivation therapy for PTEN-deficient metastatic ...

An FDA advisory panel has issued contrasting recommendations on AstraZeneca’s oncology portfolio, backing its prostate cancer ...

The ODAC voted seven to one that data from the CAPItello-281 trial showed a favorable benefit-risk profile for Truqap plus abiraterone and ADT.

The U.S. Food and Drug Administration's Oncologic Drugs Advisory Committee (ODAC) delivered mixed recommendations for ...

For the first time since last July the FDA's Oncologic Drugs Advisory Committee (ODAC) will meet on Thursday to evaluate two ...

Mark Oliver wore incontinence pads and would be ‘absolutely saturated’ in public if he could not urgently find a toilet.

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis – the ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis—the detection of a cancer that would never have been diagnosed during a patient's ...

Researchers at Queen Mary University of London have found that the likelihood of prostate cancer overdiagnosis – the detection of a cancer that would never have been diagnosed during a patient’s ...

A U.S. judge has ‌rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its ...

A recent study has found that vegetarian diets are linked to significant reductions in the risk of several types of cancer. Researchers analysed data from nearly 1.8 million people across the UK, US, ...

"There remains an urgent need for novel therapies for patients with BRCA2-mutated mCSPC, who face significantly faster disease progression and often shorter survival compared to those without the ...